Are sodium‐glucose cotransporter‐2 inhibitors safe adjunctive drugs during insulin therapy in young children with type 1 diabetes? The first case of type 1 diabetes with SLC5A2 mutation

• Mohamad Ahangar Davoodi,
• Mohammad Ali Daneshmand,
• Taraneh Rezaei

Affiliations

Mohamad Ahangar Davoodi

Department of Pediatric Endocrinology Arak University of Medical Sciences, Clinical Research Development Center of Amirkabir Hospital Arak Iran

Mohammad Ali Daneshmand

Arak University of Medical Sciences, Teacher of Pathology in Arak Medical School Arak Iran

Taraneh Rezaei

Student Research Committee Arak University of Medical Sciences Arak Iran